Examination of the Pancreas in New-onset Diabetes

NCT02001337 | Completed

• 1 other identifier: 10-006868
• Study Type: observational
• Target: 79
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer

Conditions

Diabetes Mellitus

Keywords

pancreatic cancer; new-onset diabetic; diabetes

Outcome Measures

Primary Outcomes (1)

• To create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and identify pancreatic cancer in this cohort.

  We will prospectively identify patients with newly diagnosed diabetes and perform pancreatic imaging to identify pancreatic cancer

  Follow subjects for 2 years.

Interventions

medical chart review OTHER

baseline, quarterly follow-up for 24 months

survey administration OTHER

baseline

Specimen collection OTHER

baseline

Eligibility Criteria

• Age: 50 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Suspected or definite new-onset diabetes

Patient Characteristics: --Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values * No acute illness or steroid therapy * No prior pancreas surgery

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

• Mayo Clinic Clinical Trials

Biospecimen

Retention: SAMPLES WITH DNA

60ml of whole blood. 5ml urine sample for pregancy testing (if necessary). Stool and saliva samples may be collected.

MeSH Terms

Conditions

Diabetes Mellitus; Pancreatic Neoplasms

Interventions

Specimen Handling

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Endocrine Gland Neoplasms; Digestive System Diseases; Pancreatic Diseases

Intervention Hierarchy (Ancestors)

Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Study Officials

• Gloria Petersen, PhD

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: November 22, 2013
• First Posted: December 4, 2013
• Study Start: May 1, 2013
• Primary Completion: November 30, 2016
• Study Completion: November 30, 2016
• Last Updated: November 7, 2019

Record last verified: 2019-11

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)